1. Home
  2. ARTV vs KLXE Comparison

ARTV vs KLXE Comparison

Compare ARTV & KLXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARTV
  • KLXE
  • Stock Information
  • Founded
  • ARTV 2019
  • KLXE 2018
  • Country
  • ARTV United States
  • KLXE United States
  • Employees
  • ARTV N/A
  • KLXE N/A
  • Industry
  • ARTV
  • KLXE Oilfield Services/Equipment
  • Sector
  • ARTV
  • KLXE Energy
  • Exchange
  • ARTV NYSE
  • KLXE Nasdaq
  • Market Cap
  • ARTV 41.2M
  • KLXE 35.8M
  • IPO Year
  • ARTV 2024
  • KLXE N/A
  • Fundamental
  • Price
  • ARTV $3.60
  • KLXE $1.89
  • Analyst Decision
  • ARTV Strong Buy
  • KLXE
  • Analyst Count
  • ARTV 8
  • KLXE 0
  • Target Price
  • ARTV $18.14
  • KLXE N/A
  • AVG Volume (30 Days)
  • ARTV 373.8K
  • KLXE 179.5K
  • Earning Date
  • ARTV 08-28-2025
  • KLXE 08-06-2025
  • Dividend Yield
  • ARTV N/A
  • KLXE N/A
  • EPS Growth
  • ARTV N/A
  • KLXE N/A
  • EPS
  • ARTV N/A
  • KLXE N/A
  • Revenue
  • ARTV N/A
  • KLXE $688,600,000.00
  • Revenue This Year
  • ARTV N/A
  • KLXE N/A
  • Revenue Next Year
  • ARTV N/A
  • KLXE $3.97
  • P/E Ratio
  • ARTV N/A
  • KLXE N/A
  • Revenue Growth
  • ARTV N/A
  • KLXE N/A
  • 52 Week Low
  • ARTV $1.47
  • KLXE $1.46
  • 52 Week High
  • ARTV $17.31
  • KLXE $7.66
  • Technical
  • Relative Strength Index (RSI)
  • ARTV N/A
  • KLXE 47.27
  • Support Level
  • ARTV N/A
  • KLXE $1.69
  • Resistance Level
  • ARTV N/A
  • KLXE $2.08
  • Average True Range (ATR)
  • ARTV 0.00
  • KLXE 0.16
  • MACD
  • ARTV 0.00
  • KLXE 0.02
  • Stochastic Oscillator
  • ARTV 0.00
  • KLXE 69.35

About ARTV ARTIVA BIOTHERAPEUTICS INC

Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.

Share on Social Networks: